JP2002370976A - うつ病及び不安のための併合療法 - Google Patents

うつ病及び不安のための併合療法

Info

Publication number
JP2002370976A
JP2002370976A JP2002141515A JP2002141515A JP2002370976A JP 2002370976 A JP2002370976 A JP 2002370976A JP 2002141515 A JP2002141515 A JP 2002141515A JP 2002141515 A JP2002141515 A JP 2002141515A JP 2002370976 A JP2002370976 A JP 2002370976A
Authority
JP
Japan
Prior art keywords
dichlorophenoxy
methylamine
alkyl
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002141515A
Other languages
English (en)
Japanese (ja)
Inventor
Harry Ralph Howard Jr
ラルフ ハワード，ジュニア ハリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of JP2002370976A publication Critical patent/JP2002370976A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2002141515A 2001-05-23 2002-05-16 うつ病及び不安のための併合療法 Withdrawn JP2002370976A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29306301P 2001-05-23 2001-05-23
US60/293063 2001-05-23

Publications (1)

Publication Number Publication Date
JP2002370976A true JP2002370976A (ja) 2002-12-24

Family

ID=23127491

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002141515A Withdrawn JP2002370976A (ja) 2001-05-23 2002-05-16 うつ病及び不安のための併合療法

Country Status (10)

Country Link
EP (1) EP1260221A3 (fr)
JP (1) JP2002370976A (fr)
KR (1) KR20020090152A (fr)
CN (1) CN1386504A (fr)
AU (1) AU4068102A (fr)
CA (1) CA2386287A1 (fr)
HU (1) HUP0201720A2 (fr)
IL (1) IL149705A0 (fr)
PL (1) PL354111A1 (fr)
ZA (1) ZA200204018B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1791807A1 (fr) * 2004-09-10 2007-06-06 Pfizer Products Incorporated Ligands de diphenyl ether therapeutiques
ES2533065T3 (es) 2010-07-09 2015-04-07 Pfizer Limited Bencenosulfonamidas útiles como inhibidores de los canales de sodio
US8609162B2 (en) 2012-10-04 2013-12-17 Invivo Beverages Llc Integrated neuromodulation system for mood enhancement of a living human subject
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA923283B (en) * 1991-05-29 1993-01-27 Akzo Nv Phenoxyphenyl derivatives
DE4241013A1 (de) * 1992-12-05 1994-06-09 Boehringer Ingelheim Kg Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
US5708018A (en) * 1993-08-06 1998-01-13 Pharmacia & Upjohn Company 2-aminoindans as selective dopamine D3 ligands
CN1166622C (zh) * 1995-02-01 2004-09-15 法玛西雅厄普约翰美国公司 作为选择性多巴胺d3配体的2-氨基-1,2-二氢化茚
FR2742149B1 (fr) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques
NZ512910A (en) * 1999-02-23 2003-11-28 Pfizer Prod Inc Monoamine reuptake inhibitors for treatment of CNS disorders

Also Published As

Publication number Publication date
EP1260221A3 (fr) 2002-12-18
CN1386504A (zh) 2002-12-25
AU4068102A (en) 2002-12-05
PL354111A1 (en) 2002-12-02
IL149705A0 (en) 2002-11-10
ZA200204018B (en) 2003-11-21
HUP0201720A2 (hu) 2003-07-28
HU0201720D0 (fr) 2002-07-29
EP1260221A2 (fr) 2002-11-27
CA2386287A1 (fr) 2002-11-23
KR20020090152A (ko) 2002-11-30

Similar Documents

Publication Publication Date Title
US6436938B1 (en) Combination treatment for depression
US6169105B1 (en) Potentiation of drug response
BRPI0712039A2 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pós-menopausa
JP2002308801A (ja) うつ病、強迫疾患および精神病の組み合わせ治療
TWI226829B (en) Pharmaceutical compositions for treatment of partial responders or refractory depression
JP2002370975A (ja) アルコール依存症のための併合療法
US20020107244A1 (en) Combination treatment for depression
US20030212060A1 (en) Combination therapy for treatment of refractory depression
EP0759299B1 (fr) Potentialisation de la sérotonine
US20020165217A1 (en) Combination treatment for anxiety and depression
US5958429A (en) Potentiation of serotonin response
US20020183306A1 (en) Combination treatment for sleep disorders including sleep apnea
JP2005533788A (ja) Ｐｄｅｉｖ阻害剤および抗うつ薬または不安解消薬の組み合わせによるうつ病および不安の治療
JP2008500325A (ja) 注意欠陥多動性障害の治療用の組合せ
JP2002370976A (ja) うつ病及び不安のための併合療法
JP2012508186A (ja) むずむず脚症候群および睡眠障害の治療
SK14502000A3 (sk) Kombinácie liekov n. a. r. i. (inhibítorov reaktivácie noradrenalínu), výhodne reboxetínu, a pindololu
ES2359813T3 (es) Análogos de 3alfa-(difenilmetoxi)tropano 4',4"-substituidos para el tratamiento del adhd.
MXPA00011353A (es) Uso de olanzapida en combinación con fluoxetina para terapia de la depresión refractaria

Legal Events

Date Code Title Description
A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20060216